# Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism

> **NCT03091621** · — · UNKNOWN · sponsor: **Nihon University** · enrollment: 1000 (estimated)

## Conditions studied

- Deep Vein Thrombosis
- Pulmonary Embolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03091621
- **Lead sponsor:** Nihon University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2019-11
- **Final completion:** 2019-11
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2017-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03091621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03091621, "Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03091621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*